Journal article
Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial
LC van der Heijden, MM Kok, MK Lam, PW Danse, AR Schramm, GAJ Jessurun, RM Tjon Joe Gin, KG van Houwelingen, RWM Hautvast, GCM Linssen, H Sen, MM Löwik, MJ IJzerman, CJM Doggen, C von Birgelen
Clinical Research in Cardiology | SPRINGER HEIDELBERG | Published : 2016
Abstract
Background: Percutaneous coronary intervention (PCI) in bifurcated lesions with second-generation drug-eluting stents (DES) was associated with increased myocardial infarction (MI) rates. Flexible stent designs that accommodate well to vessel tapering may be of benefit in challenging anatomies such as bifurcated target lesions, but so far data are scarce. Methods: We analyzed the 2-year follow-up data of the DUTCH PEERS (TWENTE II) trial, which randomized 1811 all-comer patients to PCI with newer generation resolute integrity zotarolimus-eluting (Medtronic) or promus element everolimus-eluting stents (Boston Scientific). In bifurcated lesions, provisional stenting was generally performed. Ta..
View full abstractGrants
Funding Acknowledgements
This investigator-initiated study was supported by equal grants from Boston Scientific and Medtronic.